$395 Million is the total value of Parkman Healthcare Partners LLC's 74 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 39.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DXCM | Sell | DEXCOM INC | $24,859,000 | +15.4% | 45,458 | -9.9% | 6.29% | +33.5% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $23,516,000 | -10.8% | 1,306,460 | -13.0% | 5.95% | +3.2% |
| DHR | Sell | DANAHER CORPORATION | $13,798,000 | -7.9% | 45,324 | -18.8% | 3.49% | +6.6% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $10,317,000 | -46.6% | 25,000 | -52.1% | 2.61% | -38.2% |
| NTRA | Sell | NATERA INC | $10,035,000 | -26.7% | 90,047 | -25.3% | 2.54% | -15.1% |
| PODD | Sell | INSULET CORP | $9,760,000 | +0.6% | 34,340 | -2.8% | 2.47% | +16.4% |
| CDMO | Sell | AVID BIOSERVICES INC | $9,707,000 | -20.3% | 450,000 | -5.3% | 2.46% | -7.8% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $8,252,000 | +21.8% | 236,637 | -4.1% | 2.09% | +41.0% |
| HUM | Sell | HUMANA INC | $7,394,000 | -48.9% | 19,000 | -41.9% | 1.87% | -40.8% |
| RGEN | Sell | REPLIGEN CORP | $5,780,000 | -25.3% | 20,000 | -48.4% | 1.46% | -13.5% |
| CTLT | Sell | CATALENT INC | $5,288,000 | -10.6% | 39,739 | -27.4% | 1.34% | +3.4% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $4,755,000 | -36.3% | 311,207 | -22.4% | 1.20% | -26.3% |
| XRAY | Sell | DENTSPLY SIRONA INC | $4,670,000 | -33.2% | 80,455 | -27.2% | 1.18% | -22.6% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $4,227,000 | -62.8% | 209,686 | -31.2% | 1.07% | -57.0% |
| AXGN | Sell | AXOGEN INC | $3,160,000 | -38.5% | 200,000 | -15.8% | 0.80% | -28.9% |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $2,893,000 | +17.9% | 69,549 | -14.0% | 0.73% | +36.6% |
| NOTV | Sell | INOTIV INC | $2,851,000 | -7.1% | 97,500 | -15.2% | 0.72% | +7.5% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $2,505,000 | -29.3% | 31,393 | -13.7% | 0.63% | -18.2% |
| OM | Sell | OUTSET MED INC | $2,489,000 | -29.2% | 50,336 | -28.4% | 0.63% | -18.0% |
| STXS | Sell | STEREOTAXIS INC | $2,421,000 | -63.0% | 450,000 | -33.7% | 0.61% | -57.2% |
| ALT | Sell | ALTIMMUNE INC | $1,979,000 | +0.5% | 175,000 | -12.5% | 0.50% | +16.2% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $1,465,000 | -73.7% | 101,961 | -71.0% | 0.37% | -69.5% |
| ONCT | Sell | ONCTERNAL THERAPEUTICS INC | $1,357,000 | -31.2% | 325,384 | -21.7% | 0.34% | -20.4% |
| ICAD | Sell | ICAD INC | $1,344,000 | -85.4% | 125,000 | -76.5% | 0.34% | -83.1% |
| BLRX | Sell | BIOLINERX LTDsponsored ads | $1,130,000 | -45.2% | 411,060 | -44.0% | 0.29% | -36.6% |
| MNKD | Sell | MANNKIND CORP | $1,109,000 | -74.7% | 255,047 | -68.3% | 0.28% | -70.7% |
| CSLT | Sell | CASTLIGHT HEALTH INCcl b | $942,000 | -47.1% | 600,000 | -11.5% | 0.24% | -39.0% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $548,000 | -67.8% | 133,449 | -66.1% | 0.14% | -62.7% |
| VERA | Sell | VERA THERAPEUTICS INCcl a | $445,000 | -55.6% | 25,638 | -66.1% | 0.11% | -48.4% |
| EYEG | Exit | EYEGATE PHARMACEUTICALS INC | $0 | – | -75,647 | -100.0% | -0.06% | – |
| AMAM | Exit | AMBRX BIOPHARMA INCsponsored ads | $0 | – | -15,000 | -100.0% | -0.06% | – |
| ARPO | Exit | AERPIO PHARMACEUTICALS INC | $0 | – | -353,957 | -100.0% | -0.13% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -49,969 | -100.0% | -0.14% | – |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -225,881 | -100.0% | -0.16% | – |
| BCEL | Exit | ATRECA INC | $0 | – | -100,628 | -100.0% | -0.19% | – |
| FBRX | Exit | FORTE BIOSCIENCES INC | $0 | – | -31,402 | -100.0% | -0.23% | – |
| TLMD | Exit | SOC TELEMED INC | $0 | – | -208,121 | -100.0% | -0.26% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -7,500 | -100.0% | -0.26% | – |
| KDMN | Exit | KADMON HLDGS INC | $0 | – | -501,740 | -100.0% | -0.42% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -211,385 | -100.0% | -0.45% | – | |
| EDAP | Exit | EDAP TMS S Asponsored adr | $0 | – | -346,926 | -100.0% | -0.54% | – |
| SPNE | Exit | SEASPINE HLDGS CORP | $0 | – | -225,000 | -100.0% | -1.01% | – |
| INFU | Exit | INFUSYSTEM HLDGS INC | $0 | – | -251,567 | -100.0% | -1.14% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -130,000 | -100.0% | -1.28% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -35,792 | -100.0% | -1.30% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -60,074 | -100.0% | -1.65% | – |
| ITMR | Exit | ITAMAR MED LTDsponsored ads | $0 | – | -338,001 | -100.0% | -1.74% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -19,613 | -100.0% | -3.94% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.